TWD 20.05
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 77.65 Million TWD | -3.55% |
2022 | 80.51 Million TWD | 19.65% |
2021 | 67.29 Million TWD | -0.84% |
2020 | 67.85 Million TWD | -16.51% |
2019 | 81.27 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 14.09 Million TWD | -28.46% |
2024 Q2 | 14.09 Million TWD | 0.0% |
2023 Q1 | 19.12 Million TWD | -9.11% |
2023 Q4 | 19.7 Million TWD | 0.0% |
2023 FY | 77.65 Million TWD | -3.55% |
2023 Q2 | 19.12 Million TWD | 0.0% |
2023 Q3 | 19.7 Million TWD | 3.02% |
2022 Q4 | 21.04 Million TWD | 0.0% |
2022 FY | 80.51 Million TWD | 19.65% |
2022 Q3 | 21.04 Million TWD | 0.0% |
2021 FY | 67.29 Million TWD | -0.84% |
2020 FY | 67.85 Million TWD | -16.51% |
2019 FY | 81.27 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | 68.491% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | 72.883% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | 54.515% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 97.591% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 96.337% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 96.384% |
Center Laboratories, Inc. | 618.09 Million TWD | 87.437% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | 72.863% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 83.432% |
InnoPharmax Inc. | 17.45 Million TWD | -344.813% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 68.258% |
Excelsior Biopharma Inc. | 306.93 Million TWD | 74.701% |
DV Biomed Co., Ltd. | 764.27 Million TWD | 89.84% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | 31.868% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 92.973% |
UniPharma Co., Ltd. | 51.01 Million TWD | -52.209% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 80.437% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | 83.334% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | 77.661% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -13016.723% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | 80.582% |